{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:54:54Z","timestamp":1793040894543,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The spectrum of disorders associated with hyperinsulinemic hypoglycemia (HHI) has vastly increased over the past 20\u00a0years with identification of molecular, metabolic and cellular pathways involved in the regulation of insulin secretion and its actions. Hereditary tyrosinemia (HT1) is a rare metabolic disorder associated with accumulation of toxic metabolites of the tyrosine pathway due to a genetically mediated enzyme defect of fumarylacetoacetate hydrolase. Transient tyrosinemia of the newborn (TTN) is a benign condition with a maturational defect of the enzymes associated with tyrosine metabolism without any genetic abnormalities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We describe two rare cases of HHI, one in a patient with HT1 and for the first time, in a patient with TTN. Each of our patients presented in the neonatal period with persistent hypoglycemia that on biochemical evaluation was consistent with HHI. Each patient received diazoxide therapy for 3.5\u00a0months and 17\u00a0months of life, respectively and HHI resolved thereafter.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Despite the fact that HHI has been described in HT1 for several decades, no specific mechanism has been delineated. Although we considered the common embryonal origin of the liver and pancreas with the hepatotoxic effect in HT1 also impacting the latter, this was not a possible explanation for TTN. The commonality between our two patients is the accumulation of certain amino acids which are known to be insulinotropic. We therefore hypothesize that the excess of amino acids such as leucine, lysine, valine and isoleucine in our patients resulted in HHI, which was transient. Both patients responded to diazoxide. This novel presentation in TTN and the reassuring response in both HT1 and TTN to diazoxide will be useful to inform physicians about managing HHI in these patients. Further studies are required to delineate the mechanism of HHI in these infants.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-01642-y","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T18:15:06Z","timestamp":1619633706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neonatal hyperinsulinism in transient and classical forms of tyrosinemia"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7101-5045","authenticated-orcid":false,"given":"Swathi","family":"Sethuram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Gujral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"1642_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10545-005-5517-1","volume":"28","author":"U Baumann","year":"2005","unstructured":"Baumann U, Preece MA, Green A, et al. Hyperinsulinism in tyrosinaemia type I. J Inherit Metab Dis. 2005;28:131\u20135. https:\/\/doi.org\/10.1007\/s10545-005-5517-1.","journal-title":"J Inherit Metab Dis"},{"key":"1642_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrgastro.2012.23","volume":"9","author":"V Cardinale","year":"2012","unstructured":"Cardinale V, Wang Y, Carpino G, et al. The biliary tree\u2014a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol. 2012;9:231\u201340. https:\/\/doi.org\/10.1038\/nrgastro.2012.23.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1642_CR3","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/gim.2017.101","volume":"19","author":"JM Chinsky","year":"2017","unstructured":"Chinsky JM, Singh R, Ficicioglu C, et al. Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations. Genet Med. 2017;19:1380.","journal-title":"Genet Med"},{"key":"1642_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1172-8-8","volume":"8","author":"C de Laet","year":"2013","unstructured":"de Laet C, Dionisi-Vici C, Leonard JV, et al. Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis. 2013;8:8. https:\/\/doi.org\/10.1186\/1750-1172-8-8.","journal-title":"Orphanet J Rare Dis"},{"key":"1642_CR5","doi-asserted-by":"crossref","unstructured":"de Leon DD, Stanley CA. Congenital hypoglycemia disorders: new aspects of etiology, diagnosis, treatment and outcomes: highlights of the proceedings of the congenital hypoglycemia disorders symposium, Philadelphia April 2016. Pediatr Diabetes. 2017;18(1):3\u20139.","DOI":"10.1111\/pedi.12453"},{"key":"1642_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/siny.2001.0090","volume":"7","author":"P de Lonlay","year":"2002","unstructured":"de Lonlay P, Touati G, Robert J-J, Saudubray J-M. Persistent hyperinsulinaemic hypoglycaemia. Semin Neonatol SN. 2002;7:95\u2013100. https:\/\/doi.org\/10.1053\/siny.2001.0090.","journal-title":"Semin Neonatol SN"},{"key":"1642_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jpeds.2015.09.045","volume":"168","author":"C Ferrara","year":"2016","unstructured":"Ferrara C, Patel P, Becker S, et al. Biomarkers of insulin for the diagnosis of hyperinsulinemic hypoglycemia in infants and children. J Pediatr. 2016;168:212\u20139. https:\/\/doi.org\/10.1016\/j.jpeds.2015.09.045.","journal-title":"J Pediatr"},{"key":"1642_CR8","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1172\/JCI105456","volume":"45","author":"JC Floyd","year":"1966","unstructured":"Floyd JC, Fajans SS, Conn JW, et al. Stimulation of insulin secretion by amino acids. J Clin Invest. 1966;45:1487\u2013502. https:\/\/doi.org\/10.1172\/JCI105456.","journal-title":"J Clin Invest"},{"key":"1642_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fendo.2019.00111","volume":"10","author":"S Galcheva","year":"2019","unstructured":"Galcheva S, Demirbilek H, Al-Khawaga S, Hussain K. The genetic and molecular mechanisms of congenital hyperinsulinism . Front Endocrinol. 2019;10:111. https:\/\/doi.org\/10.3389\/fendo.2019.00111.","journal-title":"Front Endocrinol"},{"key":"1642_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/archdischild-2015-308337","volume":"101","author":"A Ghosh","year":"2016","unstructured":"Ghosh A, Banerjee I, Morris AAM. Recognition, assessment and management of hypoglycaemia in childhood. Arch Dis Child. 2016;101:575\u201380. https:\/\/doi.org\/10.1136\/archdischild-2015-308337.","journal-title":"Arch Dis Child"},{"key":"1642_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0022-3476(60)80242-9","volume":"57","author":"MM Grumbach","year":"1960","unstructured":"Grumbach MM, Kaplan SL. Amino acid and alpha-keto acid-induced hyperinsulinism in the leucine-sensitive type of infantile and childhood hypoglycemia. J Pediatr. 1960;57:346\u201362. https:\/\/doi.org\/10.1016\/S0022-3476(60)80242-9.","journal-title":"J Pediatr"},{"key":"1642_CR12","doi-asserted-by":"crossref","unstructured":"Keane K, Newsholme P (2014) Metabolic Regulation of Insulin Secretion. In: Vitamins & Hormones. Elsevier, pp 1\u201333","DOI":"10.1016\/B978-0-12-800174-5.00001-6"},{"key":"1642_CR13","doi-asserted-by":"publisher","first-page":"e522","DOI":"10.1542\/peds.2008-0806","volume":"122","author":"A Kelly","year":"2008","unstructured":"Kelly A, Tang R, Becker S, Stanley CA. Poor specificity of low growth hormone and cortisol levels during fasting hypoglycemia for the diagnoses of growth hormone deficiency and adrenal insufficiency. Pediatrics. 2008;122:e522\u20138. https:\/\/doi.org\/10.1542\/peds.2008-0806.","journal-title":"Pediatrics"},{"key":"1642_CR14","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.1152\/ajpendo.1991.260.1.E21","volume":"260","author":"T Kuhara","year":"1991","unstructured":"Kuhara T, Ikeda S, Ohneda A, Sasaki Y. Effects of intravenous infusion of 17 amino acids on the secretion of GH, glucagon, and insulin in sheep. Am J Physiol-Endocrinol Metab. 1991;260:E21\u20136. https:\/\/doi.org\/10.1152\/ajpendo.1991.260.1.E21.","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"1642_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ajmg.c.30293","volume":"157","author":"SH Mudd","year":"2011","unstructured":"Mudd SH. Hypermethioninemias of genetic and non-genetic origin: A review. Am J Med Genet C Semin Med Genet. 2011;157:3\u201332. https:\/\/doi.org\/10.1002\/ajmg.c.30293.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"18","key":"1642_CR16","first-page":"1067","volume":"97","author":"TL Perry","year":"1967","unstructured":"Perry TL. Tyrosinemia associated with hypermethioninemia and islet cell hyperplasia. Can Med Assoc J. 1967;97(18):1067\u201375.","journal-title":"Can Med Assoc J"},{"issue":"2","key":"1642_CR17","first-page":"317","volume":"47","author":"P Russo","year":"1990","unstructured":"Russo P, O\u2019Regant S. Visceral pathology of hereditary tyrosinemia type I. Am J Hum Genet. 1990;47(2):317\u201324.","journal-title":"Am J Hum Genet"},{"key":"1642_CR18","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1210\/jc.2015-3651","volume":"101","author":"CA Stanley","year":"2016","unstructured":"Stanley CA. Perspective on the genetics and diagnosis of congenital hyperinsulinism disorders. J Clin Endocrinol Metab. 2016;101:815\u201326. https:\/\/doi.org\/10.1210\/jc.2015-3651.","journal-title":"J Clin Endocrinol Metab"},{"key":"1642_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1515\/prilozi-2015-0083","volume":"36","author":"O Stomnaroska-Damcevski","year":"2015","unstructured":"Stomnaroska-Damcevski O, Petkovska E, Jancevska S, Danilovski D. Neonatal hypoglycemia: a continuing debate in definition and management. Pril Makedon Akad Na Nauk Umet Oddelenie Za Med Nauki. 2015;36:91\u20137. https:\/\/doi.org\/10.1515\/prilozi-2015-0083.","journal-title":"Pril Makedon Akad Na Nauk Umet Oddelenie Za Med Nauki"},{"issue":"4","key":"1642_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1542\/pir.2016-0063","volume":"38","author":"A Thompson-Branch","year":"2017","unstructured":"Thompson-Branch A, Havranek T. Neonatal hypoglycemia. Pediatr Rev. 2017;38(4):147\u201357. https:\/\/doi.org\/10.1542\/pir.2016-0063.","journal-title":"Pediatr Rev"},{"key":"1642_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jpeds.2015.03.057","volume":"167","author":"PS Thornton","year":"2015","unstructured":"Thornton PS, Stanley CA, De Leon DD, et al. Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr. 2015;167:238\u201345. https:\/\/doi.org\/10.1016\/j.jpeds.2015.03.057.","journal-title":"J Pediatr"},{"key":"1642_CR22","unstructured":"Transient Tyrosinemia of the newborn. https:\/\/www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?lng=en&Expert=3402."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01642-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01642-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01642-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T18:26:53Z","timestamp":1619634413000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01642-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1642"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01642-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and patient consents were not required for this study since no personal information was used and no human experiment conducted. All data have been deidentified for the purpose of this publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent\u00a0to participate"}},{"value":"Not applicable. Consent to publish was not required for this study since no personal information was used and no human experiment conducted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SS received a travel award to present this data as a poster in the Hyperinsulinism symposium conducted at Children\u2019s Hospital of Philadelphia in September 2019. MAS is a consultant for the insulin advisory board for Novo Nordisk. JG has no competing interests. CR is a consultant for the Ascendis Advisory Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}